Diarylethene (DAE) photoswitch is a new and promising family of photochromic molecules
and has shown superior performance as a smart trigger in stimulus‐responsive materials …

Cancer accounted for 7.6 million deaths (around 13% of all deaths) worldwide in 2008.(1)
Almost 13 million cancer cases are newly diagnosed every year, and deaths are projected to …

Photodynamic therapy (PDT) requires a medical device, a photosensitizing drug and
adequate use of both to trigger biological mechanisms that can rapidly destroy the primary …

Applications of metalloporphyrins and related molecules have been extensively pursued in
the context of photodynamic therapy of cancer (PDT) and other biomedical applications. This …

The spread of resistant bacteria and the development bacterial biofilm have been two major
challenges in the application of biomaterials, causing device failure as well as tissue …

Photodynamic therapy (PDT) is a promising tumor treatment modality that can convert
oxygen into cytotoxic singlet oxygen (SO) via photosensitizer to ablate tumor growth …

Photodynamic therapy (PDT) is an emerging treatment modality for a range of disease
classes, both cancerous and noncancerous. This has brought about an active pursuit of new …

Reactive oxygen species (ROS) play key roles in cell signaling systems and homeostasis,
and they are also fundamental to photodynamic therapy (PDT). PDT efficacy can be affected …

Photodynamic therapy (PDT) is an emerging clinical modality for the treatment of a variety of
diseases. Most photosensitizers are hydrophobic and poorly soluble in water. Many new …

We offer a personal account of the discovery and development of a photosensitizer for
photodynamic therapy (PDT) of cancer, from bench to bedside. We emphasize the more …